To address this gap, we investigated the effect of DEX on PD-L1 and GILZ expression in two well-characterized human GBM cell lines, U251 and U87, which are frequently used as comparative models in glioblastoma research due to their distinct molecular and phenotypic profiles [41,42,43]. The gene discussed is TSC22D3; the disease is glioblastoma.